Concepedia

Charles Flexner

CF

Statistics

Publications

107

Citations

10.5K

H-Index

50

Active since

1977

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

Harvard University

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Charles Flexner is an author at Johns Hopkins University specializing in pharmacology, antiretroviral therapy, and antiviral therapy.

ORCID

Publications per year

1977–2023

107

Publications

107

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Diana Finzi, Joel N. Blankson, Janet D. Siliciano et al. · Nature Medicine · 1999 · 2.1K citations

, , +17

Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers

Craig W. Hendrix, Charles Flexner, R. T. MacFarland et al. · Antimicrobial Agents and Chemotherapy · 2000 · 504 citations

, , +15

The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

Brent G. Petty, David R. Cornblath, Bruce T. Adornato et al. · Annals of Neurology · 1994 · 396 citations

, , +9

Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

Craig W. Hendrix, Ann C. Collier, Michael M. Lederman et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 362 citations

, , +12

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

Alan W. Heldman, Tina V. Hartert, Stuart C. Ray et al. · The American Journal of Medicine · 1996 · 290 citations

, , +13

1–5 of 107